While Nrf2 has long been proposed to confer neuroprotection in PD, the direct impact of PD-related mutations on Nrf2 function remains incompletely characterized, particularly in terms of direct mechanistic disruptions, such as altered protein expression, impaired nuclear translocation, or transcriptional repression. Here, NFE2L2 is linked to Parkinson disease.